Literature DB >> 9795836

Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues.

J E Fernàndez1, S Deaglio, D Donati, I S Beusan, F Corno, A Aranega, M Forni, B Falini, F Malavasi.   

Abstract

Human CD38 is a 45 kD ectoenzyme endowed with ADP-ribosyl cyclase and hydrolase activities. The molecule plays a central role in lymphocyte activation, proliferation and selectin-type adhesion with endothelial cells (HEC). A HEC surface molecule displaying all the features of a CD38L has been identified by means of a mAb (Moon-1), able to block CD38-mediated adhesion processes. The 130 kD molecule recognized by Moon-1 is CD31, a member of the Ig superfamily. This paper reports on the analysis of the surface expression of CD38 and CD38L in various human tissues of adult origin and compared in some instances to the fetal (9-14 weeks) counterparts. This was achieved by means of immunohistochemical techniques and analysis of purified cell populations. Among the specimens analyzed, CD38 is expressed by a vast array of cells of lymphatic origin as well as by the skeletal and cardiac muscle fibers, the bronchi (epithelial cells), the parotid gland (ductal epithelial cells) and hepatic sinusoids. On the contrary, CD31 proved constantly expressed by HEC at high levels, independent of the organ or tissue analyzed or of the kind of vessel. Other cells expressing CD38L were found in the lymphoid compartment (follicle mantle B cells and plasma cells), in the lungs (alveolar ducts, alveoli and lymphatic vessels) and in the kidney (glomerular cells). Interestingly, no fetal organ or tissue ever expressed CD38 and its ligand. The above results were enriched by the analysis of the expression of the two molecules on purified populations including mononuclear cells from the lamina propria of the gastro-intestinal tract and broncho-alveolar lavage lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795836

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  27 in total

1.  Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease.

Authors:  A Antonelli; P Fallahi; C Nesti; C Pupilli; P Marchetti; S Takasawa; H Okamoto; E Ferrannini
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 2.  Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity.

Authors:  Frances E Lund
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

3.  Structure and enzymatic functions of human CD38.

Authors:  Hon Cheung Lee
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

4.  CD38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss.

Authors:  Frances J Drummond; John J Mackrill; Kathleen O'sullivan; Mary Daly; Fergus Shanahan; Michael G Molloy
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

5.  Soluble CD38 significantly prolongs the lifespan of memory B-cell responses.

Authors:  Xue Q Liu; Derek N J Hart; Gordon G MacPherson; Michael F Good; Michelle N Wykes
Journal:  Immunology       Date:  2008-09       Impact factor: 7.397

6.  CD38-dependent ADP-ribosyl cyclase activity in developing and adult mouse brain.

Authors:  Claire Ceni; Nathalie Pochon; Virginie Brun; Hélène Muller-Steffner; Annie Andrieux; Didier Grunwald; Francis Schuber; Michel De Waard; Frances Lund; Michel Villaz; Marie-Jo Moutin
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

7.  Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.

Authors:  S E Coupland; M Hellmich; C Auw-Haedrich; W R Lee; I Anagnostopoulos; H Stein
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

8.  Mice lacking the ADP ribosyl cyclase CD38 exhibit attenuated renal vasoconstriction to angiotensin II, endothelin-1, and norepinephrine.

Authors:  Tiffany L Thai; William J Arendshorst
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-29

Review 9.  Anti-CD38 autoantibodies in type? diabetes.

Authors:  Roberto Mallone; Paolo Cavallo Perin
Journal:  Diabetes Metab Res Rev       Date:  2006 Jul-Aug       Impact factor: 4.876

10.  ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivo.

Authors:  Tiffany L Thai; William J Arendshorst
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.